Apr 13, 2021
We welcome Dr. Ken Ho, Infectious Disease Specialist
at the University of Pittsburgh, to overview the COMPASS
Study – Community Prevalence of SARS-CoV-2 Study.
COMPASS will estimate the percentage of people affected by
SARS-CoV-2, the virus that causes COVID-19. Pitt is one of 15
sites nationwide involved in the COMPASS study that will survey
residents around the Pittsburgh area to learn who has antibodies
against SARS-CoV-2 and who is carrying the virus at the time of the
test.
Ho will detail how the study hopes to recruit 4,000 people: 500 from nursing homes and assisted living facilities, 500 from doctors’ offices and other outpatient facilities and 3,000 from the community. Recruitment will end in July or earlier if researchers meet their goal before then.
The overarching goal is to capture a cross-section of the community that represents our diverse populations and translates to data that will help us understand the epidemic better at the national and the local level.